No specific research reported the direct connection among selumetinib, SPINK1, and SLCO1B3. However, SPINK1 promoted HCC metastasis via the MEK/ERK signaling pathway (Ying et al., 2017). This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.